Skip to main content
Clinical Trials/IRCT20201225049827N1
IRCT20201225049827N1
Recruiting
Phase 3

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin–A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder, Randomized Clinical Trial Study

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
42
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Obstructive symptoms of urinary obstruction defined by IPSS and enlarged prostate on DRE examination
  • Consent to enter the study
  • Existence of LUTS symptoms
  • OAB and DO approval with biodynamics and Eurodynamics study

Exclusion Criteria

  • Patients with neurological diseases such as Parkinson's or stroke
  • Prostate or bladder cancer
  • People who have had bladder or prostate surgery in the past
  • Dissatisfaction with enrollment
  • Allergy to sulifenacin or Botox

Outcomes

Primary Outcomes

Not specified

Similar Trials